본문 바로가기
KERD
논문KCI 등재

Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea

조현순|이다혜|정유석|정규원
대한암학회 (Korean Cancer Association)|2023.01|Cancer Research and Treatment|제55권 제1호|pp. 50-60|DOI 10.4143/crt.2021.1086

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

SuicideMortalitySurvivorshipCompeting riskHead and neck neoplasmsNon-cancer deathCancer surveillance
주제분류의학일반

초록

Purpose As the survival of head and neck cancer (HNC) improves, survivors increasingly confront non-cancer–related deaths. This nationwide population-based study aimed to investigate non-cancer–related deaths in HNC survivors.Materials and Methods Data from the Korean Central Cancer Registry were obtained to characterize causes of death, mortality patterns, and survival in patients with HNC between 2006 and 2016 (n=40,890). Non-cancer-related mortality relative to the general population was evaluated using standardized mortality ratios (SMRs). The 5- and 10-year cause-specific competing risks probabilities of death (cumulative incidence function, CIF) and subdistribution hazards ratios (sHR) from the Fine-Gray models were estimated.Results Comorbidity-related mortality was frequent in older patients, whereas suicide was predominant in younger patients. The risk of suicide was greater in patients with HNC than in the general population (SMR, 3.1; 95% confidence interval [CI], 2.7 to 3.5). The probability of HNC deaths reached a plateau at 5 years (5-year CIF, 33.9%; 10-year CIF, 39.5%), whereas the probability of non-HNC deaths showed a long-term linear increase (5-year, CIF 5.6%; 10-year CIF, 11.9%). Patients who were male (sHR, 1.56; 95% CI, 1.41 to 1.72), diagnosed with early-stage HNC (localized vs. distant: sHR, 1.86; 95% CI, 1.58 to 2.21) and older age (65-74 vs. 0-44: sHR, 6.20; 95% CI, 4.92 to 7.82; ≥ 75 vs. 0-44: sHR, 9.81; 95% CI, 7.76 to 12.39) had an increased risk of non-cancer mortality.Conclusion Non-HNC–related deaths continue increasing. HNC survivors are at increased risk of suicide in the younger and comorbidity-related death in the older. Better population-specific surveillance awareness and survivorship plans for HNC survivors are warranted.

Abstract

Purpose As the survival of head and neck cancer (HNC) improves, survivors increasingly confront non-cancer–related deaths. This nationwide population-based study aimed to investigate non-cancer–related deaths in HNC survivors.Materials and Methods Data from the Korean Central Cancer Registry were obtained to characterize causes of death, mortality patterns, and survival in patients with HNC between 2006 and 2016 (n=40,890). Non-cancer-related mortality relative to the general population was evaluated using standardized mortality ratios (SMRs). The 5- and 10-year cause-specific competing risks probabilities of death (cumulative incidence function, CIF) and subdistribution hazards ratios (sHR) from the Fine-Gray models were estimated.Results Comorbidity-related mortality was frequent in older patients, whereas suicide was predominant in younger patients. The risk of suicide was greater in patients with HNC than in the general population (SMR, 3.1; 95% confidence interval [CI], 2.7 to 3.5). The probability of HNC deaths reached a plateau at 5 years (5-year CIF, 33.9%; 10-year CIF, 39.5%), whereas the probability of non-HNC deaths showed a long-term linear increase (5-year, CIF 5.6%; 10-year CIF, 11.9%). Patients who were male (sHR, 1.56; 95% CI, 1.41 to 1.72), diagnosed with early-stage HNC (localized vs. distant: sHR, 1.86; 95% CI, 1.58 to 2.21) and older age (65-74 vs. 0-44: sHR, 6.20; 95% CI, 4.92 to 7.82; ≥ 75 vs. 0-44: sHR, 9.81; 95% CI, 7.76 to 12.39) had an increased risk of non-cancer mortality.Conclusion Non-HNC–related deaths continue increasing. HNC survivors are at increased risk of suicide in the younger and comorbidity-related death in the older. Better population-specific surveillance awareness and survivorship plans for HNC survivors are warranted.

참고문헌 (56)

  1. Hall SF, "The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck", Head Neck, 22, pp.317~322 (2000)
  2. Baxi SS, "Causes of death in long-term survivors of head and neck cancer", Cancer, 120, pp.1507~1513 (2014)
  3. Kim YJ, "Increasing incidence and improving survival of oral tongue squamous cell carcinoma", Sci Rep, 10, pp.7877~ (2020)
  4. Nguyen NA, "Head and neck cancer survivorship care : a review of the current guidelines and remaining unmet needs", Curr Treat Options Oncol, 19, pp.44~ (2018)
  5. Pulte D, "Changes in survival in head and neck cancers in the late 20th and early 21st century : a period analysis", Oncologist, 15, pp.994~1001 (2010)
  6. Simpson MC, "Primary cancer vs competing causes of death in survivors of head and neck cancer", JAMA Oncol, 4, pp.257~259 (2018)
  7. Mell LK, "Predictors of competing mortality in advanced head and neck cancer", J Clin Oncol, 28, pp.15~20 (2010)
  8. Massa ST, "Competing causes of death in the head and neck cancer population", Oral Oncol, 65, pp.8~15 (2017)
  9. Kim YH, "Risk factors for competing non-cancer mortality after definitive treatment for advanced-stage head and neck cancer", Oral Dis, 24, pp.1217~1225 (2018)
  10. Shen W, "Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma : a competing risk analysis", Ann Surg Oncol, 22, pp.264~271 (2015)
  11. Vaisanen JA, "Cause-specific mortality in patients with head and neck cancer : long-term follow-up of a population-based cohort from 1986 to 2012accounting for competing risks", Oral Oncol, 79, pp.20~26 (2018)
  12. Gimeno-Hernandez J, "The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma", Acta Otolaryngol, 131, pp.840~846 (2011)
  13. Piccirillo JF, "Importance of comorbidity in head and neck cancer", Laryngoscope, 110, pp.593~602 (2000)
  14. Paleri V, "Impact of comorbidity on the outcome of laryngeal squamous cancer", Head Neck, 25, pp.1019~1026 (2003)
  15. Boje CR, "Evaluation of comorbidity in 9388 head and neck cancer patients : a national cohort study from the DAHANCA database", Radiother Oncol, 110, pp.91~97 (2014)
  16. Hess CB, "Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy", JAMA Otolaryngol Head Neck Surg, 140, pp.312~316 (2014)
  17. Laara E, "Competing risks analysis of cause-specific mortality in patients with oral squamous cell carcinoma", Head Neck, 39, pp.56~62 (2017)
  18. Forastiere AA, "Organ preservation for advanced larynx cancer : issues and outcomes", J Clin Oncol, 33, pp.3262~3268 (2015)
  19. Cohen EE, "Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer", J Clin Oncol, 32, pp.2735~2743 (2014)
  20. Lop J, "Competing mortality in oropharyngeal carcinoma according to human papillomavirus status", Head Neck, 41, pp.1328~1334 (2019)
  21. Norregaard C, "Cause-specific mortality in HPV+ and HPVoropharyngeal cancer patients : insights from a populationbased cohort", Cancer Med, 7, pp.87~94 (2018)
  22. Choi JW, "Suicide risk after cancer diagnosis among older adults : a nationwide retrospective cohort study", J Geriatr Oncol, 11, pp.814~819 (2020)
  23. Zaorsky NG, "Suicide among cancer patients", Nat Commun, 10, pp.207~ (2019)
  24. Jung YS, "Metachronous second primary malignancies after head and neck cancer in a Korean cohort(1993-2010)", PLoS One, 10, pp.e0134160~ (2015)
  25. Shin A, "Trends of human papillomavirus-related head and neck cancers in Korea : national cancer registry data", Laryngoscope, 123, pp.E30~7 (2013)
  26. Kwon M, "Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer", Ann Oncol, 25, pp.1208~1214 (2014)
  27. Takenaka Y, "Risk factors associated with competing mortality among patients with head and neck cancer in Japan", Acta Otolaryngol, 136, pp.325~329 (2016)
  28. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
  29. World Health Organization, "International statistical classification of diseases and related health problems", World Health Organization, ~ (2004)
  30. 신현영, "2014년 사망원인 통계", 대한의사협회지, 59(3), pp.221~232 (2016), 대한의사협회[DOI]
  31. Cho H, "Assessing non-cancer-related health status of US cancer patients : other-cause survival and comorbidity prevalence", Am J Epidemiol, 178, pp.339~349 (2013)
  32. Howlader N, "Improved estimates of cancer-specific survival rates from population-based data", J Natl Cancer Inst, 102, pp.1584~1598 (2010)
  33. Kahn HA, "Statistical methods in epidemiology" (1989), Oxford University Press
  34. Prentice RL, "The analysis of failure times in the presence of competing risks", Biometrics, 34, pp.541~554 (1978)
  35. Gray RJ, "A class of K-sample tests for comparing the cumulative incidence of a competing risk", Ann Stat, 16, pp.1141~1154 (1988)
  36. Fine JP, "A proportional hazards model for the subdistribution of a competing risk", J Am Stat Assoc, 94, pp.496~509 (1999)
  37. Simpson WG, "Analysis of suicide risk in patients with penile cancer and review of the literature", Clin Genitourin Cancer, 16, pp.e257~61 (2018)
  38. Coatesworth AP, "The cause of death in patients with head and neck squamous cell carcinoma", J Laryngol Otol, 116, pp.269~271 (2002)
  39. Rose BS, "Populationbased study of competing mortality in head and neck cancer", J Clin Oncol, 29, pp.3503~3509 (2011)
  40. Zapata I, "Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy", BMC Cancer, 19, pp.1241~ (2019)
  41. Zaorsky NG, "Causes of death among cancer patients", Ann Oncol, 28, pp.400~407 (2017)
  42. Pignon JP, "Meta-analysis of chemotherapy in head and neck cancer(MACH-NC) : an update on 93 randomised trials and 17, 346 patients", Radiother Oncol, 92, pp.4~14 (2009)
  43. Stoltzfus KC, "Fatal heart disease among cancer patients", Nat Commun, 11, pp.2011~ (2020)
  44. Zaorsky NG, "Stroke among cancer patients", Nat Commun, 10, pp.5172~ (2019)
  45. Statistics Korea, "Population projections for Korea: 2015-2065(based on the 2015 population census)", Statistics Korea, ~ (2016)
  46. Bank of Korea, Economic Research Institute, "Population aging:impacts and policy imperatives", Bank of Korea, Economic Research Institute, ~ (2017)
  47. Osazuwa-Peters N, "Suicide risk among cancer survivors : head and neck versus other cancers", Cancer, 124, pp.4072~4079 (2018)
  48. Oh CM, "Causes of death among cancer patients in the era of cancer survivorship in Korea : attention to the suicide and cardiovascular mortality", Cancer Med, 9, pp.1741~1752 (2020)
  49. World Health Organization, "Suicide rates, age-standardized data by country", World Health Organization, ~ (2015)
  50. "Why Koreans are killing themselves in droves" (2014)[URL]
  51. Semple CJ, "Psychosocial interventions for patients with head and neck cancer : past, present, and future", Cancer Nurs, 27, pp.434~441 (2004)
  52. Howren MB, "Psychological factors associated with head and neck cancer treatment and survivorship : evidence and opportunities for behavioral medicine", J Consult Clin Psychol, 81, pp.299~317 (2013)
  53. Murphy BA, "Advances in supportive care for late effects of head and neck cancer", J Clin Oncol, 33, pp.3314~3321 (2015)
  54. Poorolajal J, "Substance use disorder and risk of suicidal ideation, suicide attempt and suicide death : a meta-analysis", J Public Health(Oxf), 38, pp.e282~91 (2016)
  55. Ang KK, "Human papillomavirus and survival of patients with oropharyngeal cancer", N Engl J Med, 363, pp.24~35 (2010)
  56. Cohen EE, "American Cancer Society head and neck cancer survivorship care guideline", CA Cancer J Clin, 66, pp.203~239 (2016)

관련 논문AI추천

Trends in the Age-Adjusted Incidence of Head and Neck Cancer in South Korea Over the Past 20 Years임영창, 조재훈, Jeffrey D. Suh대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2025 · 제18권 제2호Trends in Head and Neck Cancer in South Korea Between 1999 and 2012조재훈, Jeffrey D. Suh대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2016 · 제9권 제3호Age- and Sex-Specific Trends in Oral Cavity Cancer Cancers in a Single Institution From 2000 to 2019 in Korea김근전, 김상연, 박정해, 방주인, 선동일, 이오형대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2023 · 제66권 제11호Risk Factors for Emergency Room Visits Among Patients With Head and Neck Cancer: A Longitudinal Cohort Study Within the Korean Healthcare System김영학, 김효준, 박주현, 서예진, 이희준, 정한신, 최나연대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2025 · 제18권 제1호Effect of National Oral Health Screening Program on the Risk of Head and Neck Cancer: A Korean National Population-Based Study권민정, 엄근용, 위찬우, 이재련, 이혜진, 이효정, 정우진대한암학회 · Cancer Research and Treatment2022 · 제54권 제3호구인두암에서 초치료에 따른 생존 분석강영, 안순현, 정우진, 박하나로대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2019 · 제62권 제1호

이 간행물의 다른 논문 (31건)

Oligometastasis: More Lessons to Be Learned김경환, 안용찬pp. 1-4Top Ten Lessons Learned from Trials in Oligometastatic CancersVivian S. Tan, David A. Palmapp. 5-14Adherence to Cancer Prevention Guidelines and Cancer Incidence and Mortality: A Population-Based Cohort Study박은영, 한민지, 오진경, 김병미pp. 15-27Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing–Based NTRK Fusion Detection in South Korea최윤라, 강준, 이승은, 심효섭, 전윤경, 이미숙, 김지훈pp. 28-40Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study정재욱, 이주호, 김인아, 김영경, 임정호, 박신형, 김주영, 윤홍인, 서창옥, 안승도, 김일한, 임도훈, 김현주pp. 41-49
원문 보기